115 related articles for article (PubMed ID: 16254351)
1. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
Nanda A; Lynch DM; Goudsmit J; Lemckert AA; Ewald BA; Sumida SM; Truitt DM; Abbink P; Kishko MG; Gorgone DA; Lifton MA; Shen L; Carville A; Mansfield KG; Havenga MJ; Barouch DH
J Virol; 2005 Nov; 79(22):14161-8. PubMed ID: 16254351
[TBL] [Abstract][Full Text] [Related]
2. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses.
Shayakhmetov DM; Li ZY; Ternovoi V; Gaggar A; Gharwan H; Lieber A
J Virol; 2003 Mar; 77(6):3712-23. PubMed ID: 12610146
[TBL] [Abstract][Full Text] [Related]
3. New insights on adenovirus as vaccine vectors.
Lasaro MO; Ertl HC
Mol Ther; 2009 Aug; 17(8):1333-9. PubMed ID: 19513019
[TBL] [Abstract][Full Text] [Related]
4. HDAd6/35++ - A new helper-dependent adenovirus vector platform for
Wang H; Georgakopoulou A; Zhang W; Kim J; Gil S; Ehrhardt A; Lieber A
Mol Ther Methods Clin Dev; 2023 Jun; 29():213-226. PubMed ID: 37081854
[TBL] [Abstract][Full Text] [Related]
5. Development of adenoviral vectors that transduce Purkinje cells and other cerebellar cell-types in the cerebellum of a humanized mouse model.
Kul E; Okoroafor U; Dougherty A; Palkovic L; Li H; Valiño-Ramos P; Aberman L; Young SM
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101243. PubMed ID: 38605812
[TBL] [Abstract][Full Text] [Related]
6. The use of adenoviral vectors in gene therapy and vaccine approaches.
Araújo NM; Rubio IGS; Toneto NPA; Morale MG; Tamura RE
Genet Mol Biol; 2022; 45(3 Suppl 1):e20220079. PubMed ID: 36206378
[TBL] [Abstract][Full Text] [Related]
7. Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.
Coughlan L
Front Immunol; 2020; 11():909. PubMed ID: 32508823
[TBL] [Abstract][Full Text] [Related]
8. Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.
Matchett WE; Anguiano-Zarate SS; Nehete PN; Shelton K; Nehete BP; Yang G; Dorta-Estremera S; Barnette P; Xiao P; Byrareddy SN; Villinger F; Hessell AJ; Haigwood NL; Sastry KJ; Barry MA
J Virol; 2019 May; 93(10):. PubMed ID: 30842321
[TBL] [Abstract][Full Text] [Related]
9. Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses.
Matchett WE; Anguiano-Zarate SS; Barry MA
Glob Vaccines Immunol; 2018 Sep; 3(1):. PubMed ID: 30740532
[TBL] [Abstract][Full Text] [Related]
10. Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.
Bayon E; Morlieras J; Dereuddre-Bosquet N; Gonon A; Gosse L; Courant T; Le Grand R; Marche PN; Navarro FP
NPJ Vaccines; 2018; 3():46. PubMed ID: 30302284
[TBL] [Abstract][Full Text] [Related]
11. Progress in Adenoviral Capsid-Display Vaccines.
Vujadinovic M; Vellinga J
Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30049954
[TBL] [Abstract][Full Text] [Related]
12. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
de Andrade Pereira B; Maduro Bouillet LE; Dorigo NA; Fraefel C; Bruna-Romero O
PLoS One; 2015; 10(12):e0145260. PubMed ID: 26679149
[TBL] [Abstract][Full Text] [Related]
14. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?
Fausther-Bovendo H; Kobinger GP
Hum Vaccin Immunother; 2014; 10(10):2875-84. PubMed ID: 25483662
[TBL] [Abstract][Full Text] [Related]
16. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
Crosby CM; Nehete P; Sastry KJ; Barry MA
J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
[TBL] [Abstract][Full Text] [Related]
17. Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.
Teigler JE; Kagan JC; Barouch DH
J Virol; 2014 Sep; 88(18):10354-63. PubMed ID: 24991003
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity to adenovirus.
Hendrickx R; Stichling N; Koelen J; Kuryk L; Lipiec A; Greber UF
Hum Gene Ther; 2014 Apr; 25(4):265-84. PubMed ID: 24512150
[TBL] [Abstract][Full Text] [Related]
19. Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.
Richardson JS; Pillet S; Bello AJ; Kobinger GP
J Virol; 2013 Apr; 87(7):3668-77. PubMed ID: 23302894
[TBL] [Abstract][Full Text] [Related]
20. Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5.
Toivonen R; Koskenvuo J; Merentie M; Söderström M; Ylä-Herttuala S; Savontaus M
Virol J; 2012 Nov; 9():296. PubMed ID: 23190872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
